Page 23 - 74_02

VOL. 74 (2), 181-201, 2008 ARILESTERASA. ASPECTOS METODOLÓGICOS...

(28) ERDOS, E. G.; DEBAY, C. R. and WESTERMAN, M. P. (1960): Arylesterase in
(29) blood: effect of calcium and inhibitors. Biochem. Pharmacol. 5: 173-186.
AVIRAM, M.; ROSENBLAT, M.; BILLECKE, S.; EROGUL, J.; SORENSON, R.; BISGAIER, C.
(30) L.; NEWTON, R. S. and LA DU, B. (1999): Human serum paraoxonase (PON1)
(31) is inactivated by oxidized low density lipoprotein and preserved by antioxi-
(32) dants. Free Rad. Biol. Med. 26: 892-904.
(33) MACKNESS, M. I. (1998): Why plasma should not be used to study paraoxona-
se. Atherosclerosis. 136: 195-196.
(34) MACKNESS, B.; HINE, D.; LIU, Y.; MASTORIKOU, M. and MACKNESS, M. (2004):
(35) Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothe-
(36) lial cells. Biochem. Biophys. Res. Commun. 318: 680-683.
(37) TERESI, J. D. and LUCK, J. M. (1948): The combination of organic anions with
(38) serum albumin. J. Biol. Chem. 6: 653-661.
ORTIGOZA-FERADO, J.; RICHTER, R. J.; HORNUNG, S. K.; MOTULSKY, A. G. and
FURLONG, C. E. (1984): Paraoxon hydrolysis in human serum mediated by
a genetically variable arylesterase and albumin. Am. J. Hum. Genet. 36:
295-305.
FERRÉ, N.; CAMPS, J.; PRATS, E.; VILELLA, E.; PAUL, A.; FIGUERA, L. and JOVEN, J.
(2002): Serum paraoxonase activity: a neww additional test for the improved
evaluation of chronic liver damage. Clin. Chem. 48: 261-268.
NGUYEN, S. D. and SOK, D. E. (2006): Preferable stimulation of PON1 aryles-
terase activity by phosphatidylcholines with unsaturated acyl chains or oxi-
dized acyl chains at sn-2 position. Biochim. Biophys. Acta. 1758: 499-508.
GAN, K. N.; ECKERSON, H. W. and LA DU, B. N. (1991): Drug Metab. Dispos. 19:
100.
BARGOTA, R. S.; AKHTAR, M.; BIGGADIKE, K.; GANI, D. and ALLEMANN, R. K. (2003):
Structure-Activity relationship on human serum paraoxonase (PON 1) using
substrate analogues and inhibitors. Bioinorg. Med. Chem. Lett. 13: 1623-1626.
AVIRAM, M.; ROSENBLAT, M.; BILLECKE, S.; EROGUL, J.; SORENSON, R.; BISGAIER, C.
L.; NEWTON, R. S. and LA DU, B. (1999): Human serum paraoxonase (PON1)
is inactivated by oxidized low density lipoprotein and preserved by antioxi-
dants. Free Rad. Biol. Med. 26: 892-904.

201